|
AU2016350219A1
|
|
Innovative preparation and crystallization of iosimenol
|
|
AU2012247015A1
|
|
Ingestible event marker systems
|
|
AU2012244231A1
|
|
In-body power source having high surface area electrode
|
|
AU2012216694A1
|
|
Body-associated receiver and method
|
|
AU2011250717A1
|
|
Pharma-informatics system
|
|
AU2011204798A1
|
|
Communication system with partial power source
|
|
AU2010203737A1
|
|
Pharmaceutical dosages delivery system
|
|
AU2010203738A1
|
|
High-throughput production of ingestible event markers
|
|
AU2008329620A1
|
|
Transbody communication systems employing communication channels
|
|
AU2008210291A1
|
|
Ingestible event marker systems
|
|
AU2004201897A1
|
|
Methods for assaying antibody and device for assaying antibody
|
|
AU7533991A
|
|
M-csf derivatives, expression vectors for said derivatives, transformants carrying said vectors and production of these
|
